Aeterna Zentaris announces details regarding transaction with Ceapro

Aeterna Zentaris announces that it has finalized certain details regarding the previously announced merger of equals transaction with Ceapro. On May 3, 2024, the Company completed a share consolidation of its common shares on the basis of one post-Consolidation Common Share for every four pre-Consolidation Common Shares. As a result of the Consolidation, the exchange ratio to be used in connection with the issuance of Common Shares to Ceapro shareholders under the Transaction has been adjusted. On closing of the Transaction, Ceapro shareholders will now receive 0.02360 of a Common Share for each Ceapro share held. As part of the Transaction, holders of Common Shares as of the close of business on May 29, 2024 will receive 0.47698 of a Common Share purchase warrant on May 31, 2024 for each post-Consolidation Common Share.